Altimmune, Inc. (ALT) Balance Sheet
As of 2026-06-30 (10-Q), Altimmune, Inc. (ALT) reported total assets of $527.2M, total liabilities of $53.0M and shareholders' equity of $474.2M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $63.0M. Long-term debt: $34.7M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ALTAltimmune, Inc.Follow ALT — free
—
Price chart with a free account
- Market cap
- 412.4M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 11.2 | 12.7 | 10.5 | 18.6 | 15.6 | 2.9 | 8.8 | 33.7 | 9.0 | 115.9 | 190.3 | 111.1 | 135.1 | 36.9 | 43.8 | 63.0 | |
| Short-term investments | — | — | — | — | 0.0 | 66.8 | — | — | 28.3 | 100.0 | — | 73.8 | 62.7 | 95.0 | 229.7 | 263.3 | |
| Receivables | 3.0 | — | 3.6 | 0.4 | — | — | — | — | — | — | — | 0.2 | 1.1 | 0.5 | 1.2 | 3.3 | |
| Current assets | 19.6 | 19.8 | 14.3 | 19.3 | 17.2 | 4.5 | 23.5 | 39.4 | 39.4 | 230.3 | 204.1 | 192.8 | 209.6 | 137.3 | 278.2 | 334.8 | |
| Total assets | 22.8 | 22.7 | 17.1 | 22.0 | 19.9 | 38.4 | 63.0 | 54.8 | 54.1 | 245.1 | 218.9 | 206.9 | 210.6 | 139.3 | 279.9 | 527.2 | |
| Current liabilities | 4.6 | 7.5 | 6.8 | 2.6 | 2.2 | 5.5 | 3.8 | 4.5 | 3.9 | 12.0 | 18.3 | 17.1 | 12.1 | 10.5 | 15.0 | 12.5 | |
| Long-term debt | — | 1.7 | 0.7 | — | — | 0.5 | 0.6 | 1.9 | 1.9 | 1.8 | 1.5 | 4.6 | — | — | 34.3 | 34.7 | |
| Short-term debt | — | 0.7 | 1.0 | 0.7 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | |
| Total liabilities | 7.0 | 11.1 | 9.8 | 3.7 | 3.2 | 6.2 | 14.4 | 6.4 | 8.5 | 19.2 | 19.7 | 21.6 | 16.5 | 15.8 | 55.0 | 53.0 | |
| Shareholders' equity | 15.9 | 11.7 | 7.3 | 18.3 | 43.1 | 32.2 | 39.4 | 48.3 | 45.5 | 225.9 | 199.1 | 185.3 | 194.1 | 123.5 | 224.9 | 474.2 |
USD millions · SEC XBRL
Altimmune, Inc. — questions
- How much cash does Altimmune, Inc. have?
- $63.0M in cash and cash equivalents as of 2026-06-30.
- How much debt does Altimmune, Inc. have?
- $34.7M of long-term debt as of 2026-06-30.
- What are Altimmune, Inc.'s total assets?
- $527.2M as of 2026-06-30.
- What is Altimmune, Inc.'s shareholders' equity?
- $474.2M as of 2026-06-30.
Every figure on this page comes from Altimmune, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.